Inter Press Service examines global malaria map

NewsGuard 100/100 Score

Inter Press Service examines the Malaria Atlas Project, which tracks the presence of malaria parasites to generate a geostatistical map from a "constantly increasing number of surveys that meet required standards - 14,000 at last count."

The map, which is the "first global map of malaria endemicity since 1968," helps to provide a detailed understanding of who is at risk of contracting malaria and can assist with effectively using the approximately $1 billion per year that is spent to combat malaria, IPS writes. Its objective is to guide the "intensity" of disease control interventions in high risk areas, "monitor progress and steer the adoption of locally-appropriate interventions everywhere by 2010" in line with the WHO's strategy, according to the news service.

One of the creators of the map, Bob Snow, said, "What we do know is that the proper use of funds to protect people from mosquito bites and prompt use of effective drugs when someone is sick can massively reduce the burden of malaria." He points to evidence from Kilifi, Kenya, where the prevalence of malaria cases dropped significantly after the government started distributing insecticide-treated nets for no cost (Mulama, 8/6).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows